SIRT6 is found to be upregulated in hepatocellular carcinoma, breast cancer, ovarian cancer, esophageal cancer, lung cancer, osteosarcoma, papillary thyroid cancer, and prostate cancer [20, 21, 22, 23, 24, 25]. Here, SIRT6 is linked to breast carcinoma.